{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:59:54Z","timestamp":1779166794668,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10147-025-02848-5","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T21:39:08Z","timestamp":1754775548000},"page":"2012-2021","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk factors for second primary cancers in patients with curatively resected gastric cancer"],"prefix":"10.1007","volume":"30","author":[{"given":"Kiyoshi","family":"Wakao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidemasa","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Takamizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayuko","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3118-1791","authenticated-orcid":false,"given":"Norihiro","family":"Yuasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"issue":"3","key":"2848_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"G De Manzoni","year":"2021","unstructured":"De Manzoni G, Marrelli D, Baiocchi GL et al (2021) Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"2848_CR2","doi-asserted-by":"publisher","unstructured":"Japanese Gastric Cancer Association (2021) Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer: 24:1\u201321. https:\/\/doi.org\/10.1007\/s10120-020-01042-y","DOI":"10.1007\/s10120-020-01042-y"},{"key":"2848_CR3","unstructured":"NCCN Guidelines, version 4.2024 Gastric Cancer, Principles of surveillance. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/gastric.pdf"},{"issue":"10","key":"2848_CR4","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","volume":"33","author":"F Lordick","year":"2022","unstructured":"Lordick F, Carneiro F, Cascinu S et al (2022) Gastric cancer ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol 33(10):1005\u20131020. https:\/\/doi.org\/10.1016\/j.annonc.2022.07.004","journal-title":"Ann Oncol"},{"key":"2848_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s10120-016-0615-3","volume":"20","author":"G De Manzoni","year":"2017","unstructured":"De Manzoni G, Marrelli D, Baiocchi GL et al (2017) The Italian research group for gastric cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015. Gastric Cancer 20:20\u201330","journal-title":"Gastric Cancer"},{"issue":"9","key":"2848_CR6","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1001\/jamasurg.2024.1753","volume":"159","author":"JH Lee","year":"2024","unstructured":"Lee JH, Kim J, Choi JY (2024) Feasibility of extended postoperative follow-up in patients with gastric cancer. JAMA Surg 159(9):1009\u20131017. https:\/\/doi.org\/10.1001\/jamasurg.2024.1753","journal-title":"JAMA Surg"},{"issue":"3","key":"2848_CR7","first-page":"1049","volume":"15","author":"Y Maehara","year":"1995","unstructured":"Maehara Y, Tomisaki S, Emi Y et al (1995) Clinicopathological features of patients who died with second primary cancer after curative resection for gastric cancer. Anticancer Res 15(3):1049\u20131053","journal-title":"Anticancer Res"},{"issue":"2","key":"2848_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/bjs.4758","volume":"92","author":"Y Ikeda","year":"2005","unstructured":"Ikeda Y, Saku M, Kishihara F et al (2005) Effective follow-up for recurrence or a second primary cancer in patients with early gastric cancer. Br J Surg 92(2):235\u2013239. https:\/\/doi.org\/10.1002\/bjs.4758","journal-title":"Br J Surg"},{"issue":"6","key":"2848_CR9","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3349\/ymj.2007.48.6.981","volume":"48","author":"TK Ha","year":"2007","unstructured":"Ha TK, An JY, Youn HG et al (2007) Surgical outcome of synchronous second primary cancer in patients with gastric cancer. Yonsei Med J 48(6):981\u2013987. https:\/\/doi.org\/10.3349\/ymj.2007.48.6.981","journal-title":"Yonsei Med J"},{"key":"2848_CR10","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/1471-2407-13-394","volume":"13","author":"C Kim","year":"2013","unstructured":"Kim C, Chon H, Kang B et al (2013) Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer. BMC Cancer 13:394. https:\/\/doi.org\/10.1186\/1471-2407-13-394","journal-title":"BMC Cancer"},{"issue":"1","key":"2848_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1620\/tjem.250.31","volume":"250","author":"K Amikura","year":"2020","unstructured":"Amikura K, Ehara K, Kawashima Y (2020) The risk of developing multiple primary cancers among long-term survivors five years or more after stomach carcinoma resection. Tohoku J Exp Med 250(1):31\u201341. https:\/\/doi.org\/10.1620\/tjem.250.31","journal-title":"Tohoku J Exp Med"},{"issue":"16","key":"2848_CR12","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.3748\/wjg.v12.i16.2588","volume":"12","author":"JH Lee","year":"2006","unstructured":"Lee JH, Bae JS, Ryu KW et al (2006) Gastric cancer patients at high-risk of having synchronous cancer. World J Gastroenterol 12(16):2588\u20132592. https:\/\/doi.org\/10.3748\/wjg.v12.i16.2588","journal-title":"World J Gastroenterol"},{"issue":"2","key":"2848_CR13","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s10120-015-0482-3","volume":"19","author":"SC Chen","year":"2016","unstructured":"Chen SC, Liu CJ, Hu YW et al (2016) Second primary malignancy risk among patients with gastric cancer: a nationwide population-based study in Taiwan. Gastric Cancer 19(2):490\u2013497. https:\/\/doi.org\/10.1007\/s10120-015-0482-3","journal-title":"Gastric Cancer"},{"issue":"24","key":"2848_CR14","doi-asserted-by":"publisher","first-page":"6165","DOI":"10.3390\/cancers14246165","volume":"14","author":"JH Song","year":"2022","unstructured":"Song JH, Lee Y, Heo J et al (2022) Secondary Primary Cancer after Primary Gastric Cancer: Literature Review and Big Data Analysis Using the Health Insurance Review and Assessment Service (HIRA) Database of Republic of Korea. Cancers (Basel) 14(24):6165. https:\/\/doi.org\/10.3390\/cancers14246165","journal-title":"Cancers (Basel)"},{"key":"2848_CR15","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.15278","volume":"11","author":"B Wang","year":"2023","unstructured":"Wang B, Liu L (2023) Clinical characteristics and prognostic nomogram analysis of patients with dual primary cancers with first gastric cancer: a retrospective study in China. PeerJ 11:e15278. https:\/\/doi.org\/10.7717\/peerj.15278","journal-title":"PeerJ"},{"key":"2848_CR16","unstructured":"World Health Organization (WHO) (2011) Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Geneva, Switzerland: World Health Organization"},{"issue":"5","key":"2848_CR17","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1159\/000456075","volume":"92","author":"G Saito","year":"2017","unstructured":"Saito G, Sadahiro S, Kamata H et al (2017) Monitoring of serum carcinoembryonic antigen levels after curative resection of colon cancer: cutoff values determined according to preoperative levels enhance the diagnostic accuracy for recurrence. Oncology. 92(5):276\u2013282. https:\/\/doi.org\/10.1159\/000456075","journal-title":"Oncology."},{"issue":"4","key":"2848_CR18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3978\/j.issn.2078-6891.2013.045","volume":"4","author":"GY Yang","year":"2013","unstructured":"Yang GY, Malik NK, Chandrasekhar R et al (2013) Change in CA 19\u20139 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer. J Gastrointest Oncol 4(4):361\u2013369. https:\/\/doi.org\/10.3978\/j.issn.2078-6891.2013.045","journal-title":"J Gastrointest Oncol"},{"issue":"1","key":"2848_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12957-023-02926-w","volume":"21","author":"L Yu","year":"2023","unstructured":"Yu L, Jiang R, Chen W et al (2023) Novel prognostic indicator combining inflammatory indicators and tumor markers for gastric cancer. World J Surg Oncol 21(1):50. https:\/\/doi.org\/10.1186\/s12957-023-02926-w","journal-title":"World J Surg Oncol"},{"issue":"2","key":"2848_CR20","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s12029-022-00823-1","volume":"54","author":"K Ishido","year":"2023","unstructured":"Ishido K, Tanabe S, Katada C et al (2023) Evaluation of prognostic factors for unresectable or recurrent gastric cancer treated with Nivolumab. J Gastrointest Cancer 54(2):485\u2013491. https:\/\/doi.org\/10.1007\/s12029-022-00823-1","journal-title":"J Gastrointest Cancer"},{"issue":"18","key":"2848_CR21","doi-asserted-by":"publisher","first-page":"5318","DOI":"10.3390\/jcm11185318.PMID:36142965;PMCID:PMC9500881","volume":"11","author":"SG Kim","year":"2022","unstructured":"Kim SG, Eom BW, Yoon H et al (2022) Prognostic value of preoperative systemic inflammatory parameters in advanced gastric cancer. J Clin Med 11(18):5318. https:\/\/doi.org\/10.3390\/jcm11185318.PMID:36142965;PMCID:PMC9500881","journal-title":"J Clin Med"},{"issue":"3","key":"2848_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s11523-020-00716-y","volume":"15","author":"T Yamada","year":"2020","unstructured":"Yamada T, Hayashi T, Inokuchi Y et al (2020) Impact of the neutrophil-to-lymphocyte ratio on the survival of patients with gastric cancer treated with Nivolumab monotherapy. Target Oncol 15(3):317\u2013325. https:\/\/doi.org\/10.1007\/s11523-020-00716-y. (PMID: 32319020)","journal-title":"Target Oncol"},{"key":"2848_CR23","unstructured":"Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma, 15th edn. 2017, Kanehara, Tokyo (in Japanese)"},{"key":"2848_CR24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373\u2013383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8","journal-title":"J Chronic Dis"},{"key":"2848_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205\u2013213","journal-title":"Ann Surg"},{"key":"2848_CR26","unstructured":"Cancer Registry and Statistics. Cancer Information Service, National Cancer Center, Japan. https:\/\/ganjoho.jp\/reg_stat\/statistics\/data\/dl\/index.html"},{"key":"2848_CR27","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/jjco\/hyh056","volume":"34","author":"W Ajiki","year":"2004","unstructured":"Ajiki W, Tsukuma H, Oshima A et al (2004) Cancer incidence and incidence rates in Japan in 1999: estimates based on data from 11 population-based cancer registries. Jpn J Clin Oncol 34:352\u20136","journal-title":"Jpn J Clin Oncol"},{"issue":"2","key":"2848_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/s0361-090x(03)00002-3","volume":"27","author":"P Ghadirian","year":"2023","unstructured":"Ghadirian P, Lynch HT, Krewski D (2023) Epidemiology of pancreatic cancer: an overview. Cancer Detect Prev 27(2):87\u201393. https:\/\/doi.org\/10.1016\/s0361-090x(03)00002-3","journal-title":"Cancer Detect Prev"},{"issue":"1","key":"2848_CR29","first-page":"49","volume":"76","author":"TM Mack","year":"1986","unstructured":"Mack TM, Yu MC, Hanisch R et al (1986) Pancreas cancer and smoking, beverage consumption, and past medical history. J Natl Cancer Inst 76(1):49\u201360","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2848_CR30","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s00595-020-02131-2","volume":"51","author":"R Takahashi","year":"2021","unstructured":"Takahashi R, Nunobe S, Sai N et al (2021) Pancreatic atrophy after gastrectomy for gastric cancer. Surg Today 51(3):432\u2013438. https:\/\/doi.org\/10.1007\/s00595-020-02131-2","journal-title":"Surg Today"},{"issue":"2","key":"2848_CR31","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/bjc.2015.202","volume":"113","author":"DS Thomas","year":"2015","unstructured":"Thomas DS, Fourkala EO, Apostolidou S et al (2015) Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples. Br J Cancer 113(2):268\u2013274. https:\/\/doi.org\/10.1038\/bjc.2015.202","journal-title":"Br J Cancer"},{"key":"2848_CR32","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.cca.2015.06.022","volume":"448","author":"P Stieber","year":"2015","unstructured":"Stieber P, Nagel D, Blankenburg I et al (2015) Diagnostic efficacy of CA 15\u20133 and CEA in the early detection of metastatic breast cancer. a retrospective analysis of kinetics on 743 breast cancer patients. Clin Chim Acta 448:228\u201331. https:\/\/doi.org\/10.1016\/j.cca.2015.06.022","journal-title":"Clin Chim Acta"},{"issue":"15","key":"2848_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.14715\/cmb\/2017.64.15.11","volume":"64","author":"LX Wu","year":"2018","unstructured":"Wu LX, Li XF, Chen HF et al (2018) Combined detection of CEA and CA125 for the diagnosis for lung cancer: a meta-analysis. Cell Mol Biol (Noisy-le-grand) 64(15):67\u201370","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"3","key":"2848_CR34","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S0300-5089(21)00311-4","volume":"5","author":"N Zamcheck","year":"1976","unstructured":"Zamcheck N (1976) The present status of carcinoembryonic antigen (CEA) in diagnosis, detection of recurrence, prognosis and evaluation of therapy of colonic and pancreatic cancer. Clin Gastroenterol 5(3):625\u2013638","journal-title":"Clin Gastroenterol"},{"issue":"3","key":"2848_CR35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.mam.2011.12.002","volume":"33","author":"G Fanali","year":"2012","unstructured":"Fanali G, di Masi A, Trezza V et al (2012) Human serum albumin: from bench to bedside. Mol Aspects Med 33(3):209\u2013290. https:\/\/doi.org\/10.1016\/j.mam.2011.12.002. (Epub 2011 Dec 30 PMID: 22230555)","journal-title":"Mol Aspects Med"},{"issue":"4","key":"2848_CR36","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1177\/1049909110384841","volume":"28","author":"SA \u00d1amendys-Silva","year":"2011","unstructured":"\u00d1amendys-Silva SA, Gonz\u00e1lez-Herrera MO, Texcocano-Becerra J et al (2011) Hypoalbuminemia in critically ill patients with cancer: incidence and mortality. Am J Hosp Palliat Care 28(4):253\u2013257. https:\/\/doi.org\/10.1177\/1049909110384841. (Epub 2010 Nov 7 PMID: 21057142)","journal-title":"Am J Hosp Palliat Care"},{"issue":"11","key":"2848_CR37","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1093\/annonc\/mdu274","volume":"25","author":"B Suh","year":"2014","unstructured":"Suh B, Park S, Shin DW et al (2014) Low albumin-to-globulin ratio associated with cancer incidence and mortality in generally healthy adults. Ann Oncol 25(11):2260\u20132266. https:\/\/doi.org\/10.1093\/annonc\/mdu274. (Epub 2014 Jul 23 PMID: 25057172)","journal-title":"Ann Oncol"},{"issue":"5","key":"2848_CR38","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/fampra\/cmw051","volume":"33","author":"SW Merriel","year":"2016","unstructured":"Merriel SW, Carroll R, Hamilton F et al (2016) Association between unexplained hypoalbuminaemia and new cancer diagnoses in UK primary care patients. Fam Pract 33(5):449\u2013452. https:\/\/doi.org\/10.1093\/fampra\/cmw051. (Epub 2016 Jun 25 PMID: 27343860)","journal-title":"Fam Pract"},{"issue":"10","key":"2848_CR39","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1038\/bjc.2017.313","volume":"117","author":"T K\u00fchn","year":"2017","unstructured":"K\u00fchn T, Sookthai D, Graf ME et al (2017) Albumin, bilirubin, uric acid and cancer risk: results from a prospective population-based study. Br J Cancer 117(10):1572\u20131579. https:\/\/doi.org\/10.1038\/bjc.2017.313. (Epub 2017 Sep 12. PMID: 28898231; PMCID: PMC5680462)","journal-title":"Br J Cancer"},{"issue":"12","key":"2848_CR40","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.1002\/cam4.3937","volume":"10","author":"Z Yang","year":"2021","unstructured":"Yang Z, Zheng Y, Wu Z et al (2021) Association between pre-diagnostic serum albumin and cancer risk: Results from a prospective population-based study. Cancer Med. 10(12):4054\u20134065. https:\/\/doi.org\/10.1002\/cam4.3937. (Epub 2021 May 26. PMID: 34041866; PMCID: PMC8209558)","journal-title":"Cancer Med."},{"key":"2848_CR41","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/j.1349-7006.1994.tb02364.x","volume":"85","author":"H Tsukuma","year":"1994","unstructured":"Tsukuma H, Fujimoto I, Hanai A et al (1994) Incidence of second primary cancers in Osaka residents, Japan, with special reference to cumulative and relative risks. Jpn J Cancer Res 85:339\u2013345","journal-title":"Jpn J Cancer Res"},{"key":"2848_CR42","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1046\/j.1365-2168.2002.02120.x","volume":"89","author":"A Leslie","year":"2002","unstructured":"Leslie A, Carey FA, Pratt NR et al (2002) The colorectal adenoma-carcinoma sequence. Br J Surg 89:845\u2013860","journal-title":"Br J Surg"},{"key":"2848_CR43","doi-asserted-by":"publisher","first-page":"449S","DOI":"10.1378\/chest.103.4_Supplement.449S","volume":"103","author":"JD Minna","year":"1993","unstructured":"Minna JD (1993) The molecular biology of lung cancer pathogenesis. Chest 103:449S-S456","journal-title":"Chest"},{"key":"2848_CR44","first-page":"4335","volume":"52","author":"T Matozaki","year":"1992","unstructured":"Matozaki T, Sakamoto C, Suzuki T et al (1992) p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells. Cancer Res 52:4335\u20134341","journal-title":"Cancer Res"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02848-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-025-02848-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02848-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T07:38:24Z","timestamp":1758872304000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-025-02848-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2848"],"URL":"https:\/\/doi.org\/10.1007\/s10147-025-02848-5","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,9]]},"assertion":[{"value":"17 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures were performed in accordance with the ethical standards of human experimentation and the Helsinki Declaration.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was waived because of the retrospective nature of this study (2022\u2013004).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This study was approved by our institutional ethics committee.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and animal participants"}}]}}